The study found that Sogroya was more effective than a daily growth hormone in children with NS2. The results of a sub-study on Turner syndrome are expected to be released later this year. Novo ...

Monday.com’s co-founders and co-CEOs, Roy Mann and Eran Zinman, attributed the strong performance to the company’s ...

The downward revision comes ahead of Target’s (NYSE: TGT) first-quarter results, which Bernstein analysts believe are likely ...

The beauty products retailer posted adjusted earnings per share of $0.42, topping analyst estimates of $0.39, despite revenue falling short of expectations.

The U.S. and China have agreed to a 90-day pause to soaring tariffs placed on each other, Washington has moved to slash ...

ORLANDO - United Parks & Resorts Inc. (NYSE: PRKS) reported first quarter 2025 financial results that fell short of analyst expectations on Monday. The company’s shares were dow ...

Investing.com -- Shares in AP Moeller - Maersk A/S B (CSE: MAERSKb) soared more than 12% Monday after the Danish shipping ...

Investing.com -- Trade tensions are reshaping the global economic landscape, and BlackRock (NYSE: BLK) says investors must be ...

Consolidated copper production of 30,958 tonnes in Q1 was in line with expectations, while gold production of 73,784 ounces exceeded quarterly targets due to outperformance in Manitoba. The company ...

Investing.com - An agreement between the U.S. and China to substantially lower tariffs and pause their respective levies may be the latest in a string of indicators pointing away from a global ...

The U.S. and China have agreed to suspend most of their mutual tariffs, but a 20% tariff set by President Trump on Chinese ...

Jefferies believes that a consistent operational delivery and an increase in FCF, along with potential further buy-back ...